Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Chromatogr B Analyt Technol Biomed Life Sci ; 1118-1119: 194-202, 2019 Jun 15.
Article in English | MEDLINE | ID: mdl-31059926

ABSTRACT

A rapid and sensitive liquid chromatography-mass spectrometry assay was developed and used to quantify emetic cereulide peptide exotoxin, which can be related to possible Bacillus cereus contamination in monoclonal antibody (mAb) bioprocess feeds. The assay limit of detection was 0.05 ng/mL (~1 fmol injected) and limit of quantification 0.16 ng/mL (~3 fmol injected) over a standard curve with >3 orders of magnitude linear dynamic range. The assay allowed quantification of toxin removal in an established two-step mAb purification process consisting of Protein A affinity chromatography followed by multi-modal anion exchange chromatography. Toxin content was ascertained in process stream sample fractions as well as on the Protein A affinity column. An optimized analytical method allowed separation of cereulide toxin from other mAb cell culture components within 6 min. Spiking experiments showed that samples should be collected in high (80% v/v) content acetonitrile to reduce nonspecific losses of the cereulide. The majority of mAb purification process-associated cereulide was detected in the Protein A flow through fraction, whereas only residual amounts were found in wash, strip, and elution fractions. Column cleaning-in-place (CIP) procedures were evaluated to prevent carryover between affinity capture cycles. No carryover was detected between cycles, however trace amounts of cereulide were extracted from the Protein A resin. Increasing the CIP NaOH concentration from 0.1 M to 0.5 M, and contact time from 15 min to 1 h, improved removal of residual cereulide from the resin. Applicability of CIP clearance of cereulide during Protein A chromatography was confirmed with three different mAb feeds. Post Protein A polishing, via target flow through on a multi-modal anion exchange chromatography column, resulted in a product pool with no detectable cereulide. Approximately 5 logs of reduction in cereulide concentration was obtained over the two-step chromatography process. Cereulide contamination is well known and of concern in food processing, however this research may be the first LC-MS quantification of cereulide contamination, and its clearance, in biopharmaceutical mAb processing. The analytical method may also be used to rapidly screen for cereulide contamination in upstream cell culture process streams, prior to downstream product purification. This will allow appropriate measures to be taken to reduce toxin exposure to downstream bioprocess raw materials, consumables and equipment.


Subject(s)
Antibodies, Monoclonal/chemistry , Bacterial Toxins/isolation & purification , Chromatography, Affinity/methods , Depsipeptides/isolation & purification , Staphylococcal Protein A/metabolism , Animals , Bacillus cereus , CHO Cells , Cricetinae , Cricetulus , Depsipeptides/metabolism , Limit of Detection , Linear Models , Reproducibility of Results
2.
MAbs ; 3(2): 192-202, 2011.
Article in English | MEDLINE | ID: mdl-21304272

ABSTRACT

There is a steadily increasing demand for speed, cost efficiency, and process understanding within biopharmaceutical process development. To match this, a high-throughput method for screening of cleaning-in-place (CIP) conditions for chromatography resins has been developed. The methodology includes fouling of MabSelect SuRe chromatography resin in 96-well filter plates, cleaning of the fouled resin by incubation in different CIP agents, and finally, analysis of the residual impurities on the resin after cleaning. This article describes the improvements that transformed the method from low throughput and significant manual interference to a totally automated method with high throughput and good reproducibility.


Subject(s)
Chromatography, Affinity/instrumentation , Chromatography, Ion Exchange/instrumentation , Filtration/instrumentation , High-Throughput Screening Assays/methods , Ion Exchange Resins/chemistry , Sodium Hydroxide/chemistry , Animals , Antibodies, Monoclonal/isolation & purification , Automation , CHO Cells , Chromatography, Affinity/methods , Chromatography, Ion Exchange/methods , Cricetinae , Cricetulus , Culture Media, Conditioned , Filtration/methods , High-Throughput Screening Assays/instrumentation , Reproducibility of Results
3.
Protein Sci ; 13(6): 1476-88, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15152083

ABSTRACT

Antibodies of type IgG may be divided into two classes, called lambda or kappa, depending on the type of light chain. We have identified a conserved pocket between the two domains CH1 and CL of human IgG kappa-Fab, which is not present in the lambda type. This pocket was used as a target docking site with the purpose of exploring the possibilities of designing affinity ligands that could function as such even after immobilization to gel. The idea of the design arose mainly from the results of the saturated transfer difference (STD-NMR) screening of 46 compounds identified by means of virtual docking of 60 K diverse compounds from the Available Chemicals Directory (ACD). Surface plasmon resonance (SPR) was used as an alternative method to monitor binding in solution. A total of 24 compounds belonging to a directed library were designed, synthesized, and screened in solution. They consist essentially of an amino acid condensed to a N,N'-methylated phenyl urea. STD-NMR results suggest that a small hydrophobic side chain in the condensed amino acid promotes binding, whereas a hydroxyl-group-containing side chain implies absence of STD-NMR signals. Three compounds of the directed library were immobilized and evaluated as chromatographic probes. In one case, using D-Pro as the condensed amino acid, columns packed with ligand-coupled Sepharose (Amersham Biosciences) retained two different monoclonal samples of kappa-Fab fragments with different variable regions, whereas a sample of monoclonal lambda-Fab fragments was not retained under similar chromatographic conditions.


Subject(s)
Conserved Sequence , Drug Design , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/metabolism , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/metabolism , Binding Sites , Humans , Ligands , Models, Molecular , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Peptide Library , Protein Binding , Surface Plasmon Resonance
SELECTION OF CITATIONS
SEARCH DETAIL
...